Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.

Geron

Started by caliban , Jun 14 2005 08:07 PM

Please log in to reply

334 replies to this topic

#211 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 18 July 2011 - 06:50 PM

TRADERS ABANDON SHIP ON SHARES OF GERON, SHARES DOWN 2.5% (GERN)
Zacks.com - 13 hours ago

Jul 18, 2011 (SmarTrend® Spotlight via COMTEX) -- Geron (NASDAQ:GERN - Analyst Report) is one of today's worst performing low-priced stocks, down 2.5% to $3.93 on 0.7x average daily volume ...

View the full article

#212 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 18 July 2011 - 06:50 PM

TRADERS ABANDON SHIP ON SHARES OF GERON, SHARES DOWN 2.5% (GERN)
Zacks.com - 20 hours ago

Jul 18, 2011 (SmarTrend® Spotlight via COMTEX) -- Geron (NASDAQ:GERN - Analyst Report) is one of today's worst performing low-priced stocks, down 2.5% to $3.93 on 0.7x average daily volume ...

View the full article

#213 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 18 July 2011 - 06:50 PM

TRADERS ABANDON SHIP ON SHARES OF GERON, SHARES DOWN 2.5% (GERN)
Zacks.com - 23 hours ago

Jul 18, 2011 (SmarTrend® Spotlight via COMTEX) -- Geron (NASDAQ:GERN - Analyst Report) is one of today's worst performing low-priced stocks, down 2.5% to $3.93 on 0.7x average daily volume ...

View the full article

#214 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 20 July 2011 - 07:39 PM

International Stem Cell (ISCO) Aims to Become the "Intel™ of the Stem Cell World"
TheOTCInvestor.com - 2 hours ago

By Justin Kuepper Â· Wednesday, July 20th, 2011 International Stem Cell Corp (OTCBB: ISCO), a biotechnology company focused on therapeutic biomedical research and cosmeceutical products, operating ...

View the full article

#215 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 25 July 2011 - 02:15 PM

EARNINGS WATCH: GERON IS SCHEDULED TO REPORT ITS QUARTERLY RESULTS IN 4 DAYS (GERN)
Zacks.com - 25 minutes ago

Jul 25, 2011 (SmarTrend® News Watch via COMTEX) -- Analysts, on average, expect Geron (NASDAQ:GERN - Analyst Report) to report a loss of $0.17 per share on sales of $1 million on July 29, 2011 ...

View the full article

#216 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 26 July 2011 - 01:10 PM

Regenerative Medicine Starts to Attract Attention from Investors
BiotechStockTrader.com - 2 hours ago

By Justin Kuepper on Tuesday, July 26th, 2011 Athersys Inc. (Nasdaq: ATHX), Geron Corporation (Nasdaq: GERN), Pluristem Therapeutics Inc. (Nasdaq: PSTI) and other regenerative medicine companies ...

View the full article

#217 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 28 July 2011 - 04:08 AM

US gov't does not enslave its people
MyCentralJersey.com - 8 hours ago

In his July 24 letter to the editor, Phil Geron asserts that, by providing help for an increasing number of their citizens, governments enslave their peoples. I would like to point out to Mr ...

View the full article

#218 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 28 July 2011 - 08:59 PM

Geron Q2 loss widens to $21.1M
San Jose Business Journal - 2 hours ago

Geron Corp. on Thursday reported a second quarter loss of $21.1 million, or 17 a share, widened from a loss in the same period last year of $17 million, or 18 cents a share. Menlo Park-Geron ...

Geron Q2 Net Loss Widens - Quick Facts - RTT News

View the full article

#219 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 28 July 2011 - 08:33 PM

Geron Corporation Reports 2011 Second Quarter Financial Results and Events
MarketWatch - 2 hours ago

For the second quarter of 2011, the company reported a net loss of $21.1 million, or $0.17 per share, compared to $17.0 million, or $0.18 per share, for the comparable 2010 period. Net loss for ...

View the full article

#220 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 01 August 2011 - 12:53 PM

Embryonic obsession
World Magazine - 1 hour ago

Geron Corp. began the first FDA-approved embryonic stem cell (ESC) therapy last October, in patients with spinal cord injuries. Now a second company has begun its own clinical trials. Advanced ...

View the full article

#221 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 11 August 2011 - 01:45 PM

Earnings Report Card, Regenerative Medicine Universe Edition
Seeking Alpha - 2 hours ago

An earnings release is a 'report card' of sorts for a public stem cell company. The current LPS (loss per share) standings reflect the universes' investing status. By analyzing these comparisons ...

View the full article

#222 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 19 August 2011 - 07:05 PM

Geron Stock Hits New 52-Week Low (GERN)
TheStreet.com - 1 hour ago

By TheStreet Wire 08/19/11 - 02:54 PM EDT NEW YORK (TheStreet) -- Geron Corporation (Nasdaq:GERN) hit a new 52-week low Friday as it is currently trading at $2.46, below its previous 52-week low ...

View the full article

#223 niner

Guest
16,276 posts
2,000 ₮

Location:Philadelphia

Posted 19 August 2011 - 09:04 PM

TheStreet Wire 08/19/11 - 02:54 PM EDT NEW YORK (TheStreet) -- Geron Corporation (Nasdaq:GERN) hit a new 52-week low Friday as it is currently trading at $2.46, below its previous 52-week low ...

"TheStreet.com" hates this stock, but there are analysts that are favorable on it, last time I looked. I bought some at $2.66 a share the other day.

#224 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 24 August 2011 - 03:41 PM

Regenerative Medicine Companies Trading At Huge Discounts
Seeking Alpha - 20 minutes ago

Investors need to take a 2nd or 10th or a new look at regenerative medicine (RegMed) stocks, which have suffered from marginal if any news flow concerning clinical development, disease states and ...

View the full article

#225 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 12 September 2011 - 11:31 AM

Geron to Webcast Presentations at Upcoming Investor Conferences
MarketWatch - 34 minutes ago

MENLO PARK, Calif., Sep 12, 2011 (BUSINESS WIRE) -- Geron Corporation /quotes/zigman/55630/quotes/nls/gern GERN -5.38% today announced that management will present a company overview at two ...

View the full article

#226 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 15 September 2011 - 12:20 PM

Embryonic Stems Cell Researchers Free From Controversy for at Least One More Year
MarketWatch - 1 hour ago

NEW YORK, NY, Sep 15, 2011 (MARKETWIRE via COMTEX) -- The Paragon Report examines investing opportunities in the Biotechnology Industry and provides equity research on Advanced Cell Technology ...

View the full article

#227 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 29 September 2011 - 09:00 PM

Geron Corporation Appoints John A. Scarlett As Chief Executive Officer
Reuters Key Development - 3 hours ago

View the full article

#228 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 10 October 2011 - 05:55 PM

Stem Cell Therapy: A Process With a Promise
Xconomy - 4 hours ago

Stem cells hold the promise of ushering in a new era of regenerative medicine, as scientists and engineers have made significant progress in directing these powerful cells towards use in drug ...

3 Companies Leading The Stem Cell Revolution - Seeking Alpha

View the full article

#229 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 12 October 2011 - 07:35 AM

Pipelines From Geron and Nektar Therapeutics Rich With Possible Blockbusters
PR-USA.net - 2 hours ago

In recent years the FDA has been heavily scrutinized for making the approval process more difficult for drug developers. A groundbreaking study released this year by the BIO and BioMedTracker ...

View the full article

#230 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 18 October 2011 - 12:19 PM

Stem Cell Research Mired in Controversy -- Again
MarketWatch - 3 hours ago

NEW YORK, NY, Oct 18, 2011 (MARKETWIRE via COMTEX) -- Stem Cell stocks continue to be some of the most volatile in the market. While scientists firmly believe that stem cells are the future of ...

View the full article

#231 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 20 October 2011 - 11:32 AM

Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial
MarketWatch - 2 hours ago

MENLO PARK, Calif., Oct 20, 2011 (BUSINESS WIRE) -- Geron Corporation /quotes/zigman/55630/quotes/nls/gern GERN -3.56% today announced two presentations on the company's ongoing Phase 1 clinical ...

View the full article

#232 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 20 October 2011 - 11:30 AM

Geron Corporation Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial
Reuters Key Development - 2 hours ago

View the full article

#233 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 25 October 2011 - 11:39 AM

Geron Announces Presentation At ECTRIMS/ACTRIMS
MarketWatch - 1 hour ago

MENLO PARK, Calif., Oct 25, 2011 (BUSINESS WIRE) -- Geron Corporation /quotes/zigman/55630/quotes/nls/gern GERN +3.10% today announced data on the use of GRNOPC1, oligodendrocyte progenitors ...

View the full article

like x 1

#234 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 25 October 2011 - 11:39 AM

Geron Announces Conference Call to Discuss Third Quarter Financial Results and Highlights
MarketWatch - Oct 25, 2011

MENLO PARK, Calif., Oct 25, 2011 (BUSINESS WIRE) -- Geron Corporation /quotes/zigman/55630/quotes/nls/gern GERN 0.00% will announce its financial results for the third quarter ended September 30 ...

Geron Announces Presentation At ECTRIMS/ACTRIMS - Genetic Engineering News
Geron (GERN) Updates on GRNOPC1 for Myelin Repair - StreetInsider.com
Proactive Investors USA & Canada

View the full article

#235 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 27 October 2011 - 03:07 PM

HOT STOCK: GERON, SHARES GAIN 3.5% (GERN)
Zacks.com - 2 hours ago

Oct 27, 2011 (SmarTrend® Spotlight via COMTEX) -- Geron (NASDAQ:GERN - Analyst Report) is one of today's best performing low-priced stocks, up 3.5% to $2.36 on 0.2x average daily volume.Thus far ...

View the full article

#236 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 29 October 2011 - 08:27 PM

Geron to Webcast Presentations at Upcoming Investor Conferences
Benzinga - 1 hour ago

Geron Corporation (Nasdaq: GERN) today announced that management will present a company overview at two upcoming investor conferences. Rodman & Renshaw Annual Global Investment Conference in New ...

View the full article

#237 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 29 October 2011 - 08:27 PM

Geron Announces Conference Call to Discuss Third Quarter Financial Results and Highlights
Benzinga - 8 hours ago

Geron Corporation (Nasdaq: GERN) will announce its financial results for the third quarter ended September 30, 2011 on Thursday, November 3, 2011, after the closing of the equity market. David L ...

View the full article

#238 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 30 October 2011 - 06:38 PM

Geron And InVivo: The Race To Cure Paralysis
Seeking Alpha - 5 minutes ago

A couple of years ago shares of Geron Corporation (GERN) spiked to a near billion dollar market cap - an impressive feat for a company with nothing past Phase II trials at the time - on hype ...

View the full article

#239 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 31 October 2011 - 04:13 PM

HOT STOCK: GERON, SHARES DROP 5.5% (GERN)
Zacks.com - 20 hours ago

Oct 31, 2011 (SmarTrend® Spotlight via COMTEX) -- Geron (NASDAQ:GERN - Analyst Report) is one of today's worst performing low-priced stocks, down 5.5% to $2.42 on 0.2x average daily volume.Thus ...

View the full article

#240 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 31 October 2011 - 04:13 PM

HOT STOCK: GERON, SHARES DROP 5.5% (GERN)
Zacks.com - Oct 31, 2011

Oct 31, 2011 (SmarTrend® Spotlight via COMTEX) -- Geron (NASDAQ:GERN - Analyst Report) is one of today's worst performing low-priced stocks, down 5.5% to $2.42 on 0.2x average daily volume.Thus ...

View the full article